{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:36:55Z","timestamp":1788881815843,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93136","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:17:25Z","timestamp":1758741445000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and the Risk of Acute Pancreatitis: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Carlos","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Penedones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Batel Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.20317","article-title":"Acute pancreatitis: a review","volume":"325","author":"Mederos MA","year":"2021","unstructured":"Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021, 325:382-390. 10.1001\/jama.2020.20317","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.043","article-title":"Global incidence of acute pancreatitis is increasing over time: a systematic review and meta-analysis","volume":"162","author":"Iannuzzi JP","year":"2022","unstructured":"Iannuzzi JP, King JA, Leong JH, et al.. Global incidence of acute pancreatitis is increasing over time: a systematic review and meta-analysis. Gastroenterology. 2022, 162:122-134. 10.1053\/j.gastro.2021.09.043","journal-title":"Gastroenterology"},{"key":"ref3","article-title":"Acute pancreatitis","author":"Gapp J","year":"2025","unstructured":"Gapp J, Tariq A, Chandra S. Acute pancreatitis. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000621","article-title":"Drug-induced acute pancreatitis: an evidence based classification (revised)","volume":"14","author":"Saini J","year":"2023","unstructured":"Saini J, Marino D, Badalov N, Vugelman M, Tenner S. Drug-induced acute pancreatitis: an evidence based classification (revised). Clin Transl Gastroenterol. 2023, 14:e00621. 10.14309\/ctg.0000000000000621","journal-title":"Clin Transl Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19488","article-title":"Another case of lisinopril-induced acute pancreatitis","volume":"13","author":"Baum J","year":"2021","unstructured":"Baum J, Walfish A, Fenster M, Miller Y, Kresch M. Another case of lisinopril-induced acute pancreatitis. Cureus. 2021, 13:e19488. 10.7759\/cureus.19488","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40071","article-title":"A fatal case of lisinopril-induced acute necrotizing pancreatitis","volume":"15","author":"Masarweh OM","year":"2023","unstructured":"Masarweh OM, Al-Moussally F, Meruvia Garron JP, Kunadia A, Karasik O, Asmar A. A fatal case of lisinopril-induced acute necrotizing pancreatitis. Cureus. 2023, 15:e40071. 10.7759\/cureus.40071","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83239","article-title":"Discovering a case of lisinopril-induced necrotizing pancreatitis","volume":"17","author":"Majagi A","year":"2025","unstructured":"Majagi A, Wadehra A, Tariq T, Mohamad B. Discovering a case of lisinopril-induced necrotizing pancreatitis. Cureus. 2025, 17:e83239. 10.7759\/cureus.83239","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/875512250502100205","article-title":"Fatal acute pancreatitis in a patient chronically treated with candesartan","volume":"21","author":"Gill CJ","year":"2005","unstructured":"Gill CJ, Jennings AE, Newton JB, Schwartz DE. Fatal acute pancreatitis in a patient chronically treated with candesartan. J Pharm Technology. 2005, 21:79-82. 10.1177\/875512250502100205","journal-title":"J Pharm Technology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000178281.58158.64","article-title":"Acute pancreatitis associated with irbesartan therapy","volume":"31","author":"Famularo G","year":"2005","unstructured":"Famularo G, Minisola G, Nicotra GC, De Simone C. Acute pancreatitis associated with irbesartan therapy. Pancreas. 2005, 31:294-295. 10.1097\/01.mpa.0000178281.58158.64","journal-title":"Pancreas"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C270","article-title":"Association between ACE inhibitors and acute pancreatitis in the elderly","volume":"37","author":"Cheng RM","year":"2003","unstructured":"Cheng RM, Mamdani M, Jackevicius CA, Tu K. Association between ACE inhibitors and acute pancreatitis in the elderly. Ann Pharmacother. 2003, 37:994-998. 10.1345\/aph.1C270","journal-title":"Ann Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4179","article-title":"ACE inhibitors and the risk of acute pancreatitis-a population-based case-control study","volume":"26","author":"Kuoppala J","year":"2017","unstructured":"Kuoppala J, Enlund H, Pulkkinen J, Kastarinen H, Jyrkk\u00e4 J, Happonen P, Paajanen H. ACE inhibitors and the risk of acute pancreatitis-a population-based case-control study. Pharmacoepidemiol Drug Saf. 2017, 26:853-857. 10.1002\/pds.4179","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01128-1","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of acute pancreatitis: a population-based cohort study","volume":"45","author":"Rouette J","year":"2022","unstructured":"Rouette J, Yin H, McDonald EG, Barkun A, Azoulay L. Renin-angiotensin-aldosterone system inhibitors and risk of acute pancreatitis: a population-based cohort study. Drug Saf. 2022, 45:65-74. 10.1007\/s40264-021-01128-1","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12461","article-title":"Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases","volume":"38","author":"Douros A","year":"2013","unstructured":"Douros A, Bronder E, Andersohn F, et al.. Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases. Aliment Pharmacol Ther. 2013, 38:825-834. 10.1111\/apt.12461","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/00365520600761676","article-title":"Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP)","volume":"41","author":"Eland IA","year":"2006","unstructured":"Eland IA, Sundstr\u00f6m A, Velo GP, et al.. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol. 2006, 41:1484-1490. 10.1080\/00365520600761676","journal-title":"Scand J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000225906","article-title":"Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study","volume":"9","author":"Sj\u00f6berg Bexelius T","year":"2009","unstructured":"Sj\u00f6berg Bexelius T, Garc\u00eda Rodr\u00edguez LA, Lindblad M. Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology. 2009, 9:786-792. 10.1159\/000225906","journal-title":"Pancreatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0595-8","article-title":"Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden","volume":"17","author":"Bexelius TS","year":"2017","unstructured":"Bexelius TS, Ljung R, Mattsson F, Lu Y, Lindblad M. Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden. BMC Gastroenterol. 2017, 17:36. 10.1186\/s12876-017-0595-8","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2015-000840","article-title":"No association between losartan use and acute pancreatitis in hypertensive patients","volume":"24","author":"Lai SW","year":"2017","unstructured":"Lai SW, Lin HF, Lin CL, Liao KF. No association between losartan use and acute pancreatitis in hypertensive patients. Eur J Hosp Pharm. 2017, 24:120-123. 10.1136\/ejhpharm-2015-000840","journal-title":"Eur J Hosp Pharm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3024","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"26","author":"McDonagh TA","year":"2024","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2024, 26:5-17. 10.1002\/ejhf.3024","journal-title":"Eur J Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne RA","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023, 44:3720-3826. 10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref22","article-title":"Centre for Reviews and Dissemination; University of York","author":"Centre for Reviews and Dissemination","year":"2009","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2019s guidance for undertaking reviews in health care. York Publishing Services Ltd, York, England; 2009. https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian R","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986, 7:177-188. 10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-560. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","article-title":"Publication bias","author":"Borenstein M","year":"2009","unstructured":"Borenstein M, Hedges L V, Higgins JPT, Rothstein HR. Publication bias. Introduction to Meta-analysis. Wiley, New Jersey, US; 2009. 277-294. 10.1002\/9780470743386"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1297","article-title":"Methods for evidence synthesis in the case of very few studies","volume":"9","author":"Bender R","year":"2018","unstructured":"Bender R, Friede T, Koch A, Kuss O, Schlattmann P, Schwarzer G, Skipka G. Methods for evidence synthesis in the case of very few studies. Res Synth Methods. 2018, 9:382-392. 10.1002\/jrsm.1297","journal-title":"Res Synth Methods"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2022.107303","article-title":"Using the bayesmeta R\u00a0package for Bayesian random-effects meta-regression","volume":"229","author":"R\u00f6ver C","year":"2023","unstructured":"R\u00f6ver C, Friede T. Using the bayesmeta R\u00a0package for Bayesian random-effects meta-regression. Comput Methods Programs Biomed. 2023, 229:107303. 10.1016\/j.cmpb.2022.107303","journal-title":"Comput Methods Programs Biomed"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study","volume":"78","author":"Chen R","year":"2021","unstructured":"Chen R, Suchard MA, Krumholz HM, et al.. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension. 2021, 78:591-603. 10.1161\/HYPERTENSIONAHA.120.16667","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(23)01216-7","article-title":"575 Risk of acute pancreatitis with the use of reninangiotensin-aldosterone system inhibitors: a multicenter matched cohort study","volume":"1016","author":"Krishnan A","year":"2023","unstructured":"Krishnan A, Hadi Y, Zitun M, Singh S, Thakkar S. 575 Risk of acute pancreatitis with the use of reninangiotensin-aldosterone system inhibitors: a multicenter matched cohort study. Gastroenterology. 2023, 1016:0016-5085. 10.1016\/S0016-5085(23)01216-7","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01485.x","article-title":"Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis","volume":"17","author":"Lancashire RJ","year":"2003","unstructured":"Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003, 17:887-893. 10.1046\/j.1365-2036.2003.01485.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref33","article-title":"Angiotensin-converting enzyme inhibitors (ACEI)","author":"Herman LL","year":"2023","unstructured":"Herman LL, Padala SA, Ahmed I, Bashir K. Angiotensin-converting enzyme inhibitors (ACEI). StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00832-3","article-title":"Real-world evidence of the top 100 prescribed drugs in the USA and their potential for drug interactions with Nirmatrelvir; Ritonavir","volume":"25","author":"Gerhart J","year":"2023","unstructured":"Gerhart J, Draica F, Benigno M, et al.. Real-world evidence of the top 100 prescribed drugs in the USA and their potential for drug interactions with Nirmatrelvir; Ritonavir. AAPS J. 2023, 25:73. 10.1208\/s12248-023-00832-3","journal-title":"AAPS J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001956","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and pancreatitis: a potential dose-dependent relationship","volume":"7","author":"Hussain MS","year":"2020","unstructured":"Hussain MS, Deliwala SS, Ponnapalli A, Modi V, Kanugula A, Elbedawi MM, Bachuwa G. Angiotensin-converting enzyme (ACE) inhibitors and pancreatitis: a potential dose-dependent relationship. Eur J Case Rep Intern Med. 2020, 7:001956. 10.12890\/2020_001956","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000814","article-title":"Lisinopril-induced acute pancreatitis","volume":"26","author":"Thumma S","year":"2019","unstructured":"Thumma S, Errico K, Manchala V, Mattana J. Lisinopril-induced acute pancreatitis. Am J Ther. 2019, 26:e555-e558. 10.1097\/MJT.0000000000000814","journal-title":"Am J Ther"},{"key":"ref37","unstructured":"Medicines & Healthcare products Regulatory Agency. Summary of Product Characteristics of Coozar\u00ae. nd. (2025). Accessed. April 26, 2025: https:\/\/www.gov.uk\/guidance\/find-product-information-about-medicines#spcs."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.95.5.1115","article-title":"Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans","volume":"95","author":"Hornig B","year":"1997","unstructured":"Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation. 1997, 95:1115-1118. 10.1161\/01.cir.95.5.1115","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704462","article-title":"Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats","volume":"135","author":"Hirata M","year":"2002","unstructured":"Hirata M, Hayashi I, Yoshimura K, et al.. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. Br J Pharmacol. 2002, 135:29-36. 10.1038\/sj.bjp.0704462","journal-title":"Br J Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.053322","article-title":"Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats","volume":"307","author":"Yamada T","year":"2003","unstructured":"Yamada T, Kuno A, Masuda K, et al.. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther. 2003, 307:17-23. 10.1124\/jpet.103.053322","journal-title":"J Pharmacol Exp Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.890","article-title":"Sex differences in outcomes of acute pancreatitis: findings from a nationwide analysis","volume":"28","author":"Sharma S","year":"2021","unstructured":"Sharma S, Weissman S, Aburayyan K, et al.. Sex differences in outcomes of acute pancreatitis: findings from a nationwide analysis. J Hepatobiliary Pancreat Sci. 2021, 28:280-286. 10.1002\/jhbp.890","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000236733.31617.52","article-title":"Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review","volume":"33","author":"Yadav D","year":"2006","unstructured":"Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006, 33:323-330. 10.1097\/01.mpa.0000236733.31617.52","journal-title":"Pancreas"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60649-8","article-title":"Acute pancreatitis","volume":"21","author":"Lankisch PG","year":"2015","unstructured":"Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015, 21:85-96. 10.1016\/S0140-6736(14)60649-8","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2024.07.019","article-title":"Drug-induced pancreatitis: study of 38 patients","volume":"163","author":"Domingo-Carnice A","year":"2024","unstructured":"Domingo-Carnice A, Rodr\u00edguez D, Ordo\u00f1ez P, Llop R, Salord S, Hereu P. Drug-induced pancreatitis: study of 38 patients. Med Clin (Barc). 2024, 163:557-563. 10.1016\/j.medcli.2024.07.019","journal-title":"Med Clin (Barc)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412335-angiotensin-converting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-the-risk-of-acute-pancreatitis-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:17:28Z","timestamp":1758741448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412335-angiotensin-converting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-the-risk-of-acute-pancreatitis-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.93136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}